Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.7 |
mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.027 | 0.7 |
mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.8 |
mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |